Navigation Links
Pennsylvania Health Plans Employ Various Strategies to Combat Cost of Specialty Drugs
Date:4/8/2008

With No Generic Alternatives For Specialty Drugs, Insurers Try Intensive

Cost-management Measures, According to a New Report from

HealthLeaders-InterStudy

NASHVILLE, Tenn., April 8, 2008 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that the high cost of specialty drugs is forcing Pennsylvania insurers to get creative in finding ways to control those costs. Specialty drugs -- medications developed through a biological process that are generally injected or infused -- are rising at a rate twice to three times the pace of traditional medications. According to the latest Pennsylvania Health Plan Analysis, health plans across the state are employing various pharmacy management strategies in an attempt to control the rising cost for therapies that can range from $5,000 to $10,000 to $15,000 per month.

"So far, the health plans are opting to manage the cost of these drugs rather than shifting the cost on to health plan members," states Chris Lewis, analyst for HealthLeaders-InterStudy and author of the report. "Health plans are turning to formulary management, prior authorization, use of specialty pharmacies and shifting more biologics from the medical to the pharmacy side of the benefit design in an effort to control costs."

UPMC Health Plan in Pittsburgh, which is in its sixth year of its specialty pharmacy management program, utilizes a combination of prior authorization and step therapy, as well as purchasing medications at a discount through its preferred specialty pharmacy, CuraScript. UPMC puts all specialty drugs on the third copay tier usually reserved for non-preferred brands, with biologics users paying the highest copay.

Independence Blue Cross spends $400 million a year on biologics out of a total drug budget of about $1.5 billion. The health plan's pharmacy benefits manager, FutureScripts, capitalizes on its ability to control both the medical and pharmacy benefits under one roof. Just like for traditional pharmaceuticals, a committee of physicians and pharmacists examines the biologic drugs in the context of the targeted disease and determines whether they are better than existing therapies. In 2006 the health plan started making injectables available through the pharmacy rather than a medical office, if it was available.

About Health Plan Analysis

Health Plan Analysis identifies key health plan trends, allowing healthcare businesses to create comprehensive strategic plans and sales strategies at state and local levels.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a company of Decision Resources, Inc., is the authoritative source for managed care data and analysis. For more information, please visit http://www.HealthLeaders-InterStudy.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pennsylvania Health Secretary Focuses on Changing the Climate of Health Care During National Public Health Week
2. Dialysis Corporation of America Announces the Development of a New Facility in Pennsylvania
3. Pennsylvania Patient Safety Authority Releases March Advisory Highlighting Communication Issues That Affect Patient Safety
4. Three Out of Four Pennsylvania Voters Support Increased State Funding for Home Healthcare Services
5. The Pennsylvania Breast Cancer Coalition Announces Event at the University of Pennsylvania Hospital to Celebrate the 2008 Income Tax Check-Off Campaign
6. Governor Rendell Says Pennsylvania is One Step Closer to Providing Access to Health Care for Pennsylvanias Uninsured
7. Pennsylvania Dental Association Urges Members to Use New ADA Educational Material
8. Health Secretary Calls for Action on Health Insurance for All Pennsylvanians During Visit to Alma Illery Center in Pittsburgh
9. The Pennsylvania Breast Cancer Coalition Announces Last Chance to Enter Makeover for Mom Contest
10. Pennsylvania Health Secretary Visits Westmoreland County to Urge Passage of Health Insurance for All Pennsylvanians
11. Health Secretary Visits Lawrence County to Call for Health Insurance for All Pennsylvanians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... Somnoware, a leading provider of digital ... module. Using this new feature, sleep physicians can now predict the likelihood of ... airway pressure (CPAP), oral, or other forms of sleep apnea therapy. The Somnoware ...
(Date:4/25/2017)... ... April 25, 2017 , ... There is no better place in ... a special report in the May issue of Consumer Reports focused on heart health. ... for results achieved during and after coronary bypass and aortic valve replacement procedures. ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... instrument solutions, announces the continuation of its strategic partnership with and platinum sponsorship ... developing nations in the safe and effective management of complex spine deformity cases, ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s ... bundles, which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use ...
(Date:4/24/2017)... ... April 24, 2017 , ... The Santana Telehealth Project was honored with the ... the American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I ... improve the lives of the poor and underserved in other parts of the world,” ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), a ... significant unmet medical needs, today announced that it ... product development program, based on its proprietary self-delivering ... Dermatology (SID) 76 th Annual Meeting.  The ... sciences relevant to skin health and disease through ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
(Date:4/20/2017)... -- Research and Markets has announced the addition ... Analysis By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, ... report to their offering. ... The Latin American pharmaceutical contract manufacturing services market is ... Low drug registration cost in Latin American countries and continuous ...
Breaking Medicine Technology: